AtriCure (ATRC) Capital Expenditures (2010 - 2026)

AtriCure (ATRC) has 17 years of Capital Expenditures data on file, last reported at $1.1 million in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $1.1 million, down 7.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (down 89.95% YoY), and the FY2025 annual result was $1.3 million, down 88.99% from the prior year.
• Capital Expenditures improved to $1.1 million in Q1 2026 per ATRC's latest filing, from -$6.2 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $10.3 million in Q4 2024 and troughed at -$6.2 million in Q4 2025.
• A 5-year average of $911470.6 and a median of $787000.0 in 2023 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2023 and 2025: Capital Expenditures tumbled 654.73% in 2023, then soared 24680.0% in 2025.
• A 5-year view of Capital Expenditures shows it stood at -$1.6 million in 2022, then surged by 143.34% to $713000.0 in 2023, then surged by 1341.09% to $10.3 million in 2024, then plunged by 160.2% to -$6.2 million in 2025, then surged by 117.38% to $1.1 million in 2026.
• Business Quant data shows ATRC's Capital Expenditures at $1.1 million in Q1 2026, -$6.2 million in Q4 2025, and $2.6 million in Q3 2025.